510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-3085-2017Class I

CS 100i Intra-Aortic Balloon Pump. It supports the heart's left ventricle by increasing coronary perfusion...

Datascope Corp. / initiated 2017-07-17 / Open, Classified

Maquet Datascope Corp - Cardiac Assist Division began a recall of CS 100i Intra-Aortic Balloon Pump. It supports the heart's left ventricle by increasing coronary perfusion and reducing left ventricular work. Coronary... on . FDA classified it as Class I and gives the reason as "False blood back detection alarm and the ingress of fluids into the IABP affecting various electronic circuit boards could potentially prevent initiation or continuation of therapy". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-3085-2017
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Datascope Corp.
Product
CS 100i Intra-Aortic Balloon Pump. It supports the heart's left ventricle by increasing coronary perfusion and reducing left ventricular work. Coronary perfusion is increased by augmenting blood pressure during the diastolic phase of the cardiac cycle. This increase in aortic pressure promotes more blood flow through the coronary arteries. Left ventricular work is reduced by decreasing aortic end diastolic pressure and reducing resistance to ventricular ejection, resulting in a decrease in blood pressure during the systolic phase of the cardiac cycle.
Product code
DSP System, Balloon, Intra-Aortic And Control
Reason for recall
False blood back detection alarm and the ingress of fluids into the IABP affecting various electronic circuit boards could potentially prevent initiation or continuation of therapy.
FDA root cause
Under Investigation by firm
Action
On July 17, 2017, Maquet/Getinge distributed Urgent Product Recall Medical Device Field Correction and Response Form notices to their U.S. customers via FedEx. Urgent Field Safety Medical Device Field Correction notices were distributed to international customers via email and courier service. Maquet/Getinge advised affected customers to perform risk-benefit assessments with their respective medical team for each patient, when no alternative IABP or alternative therapy is available. Maquet/Getinge provided general information and overall action for the user informing them that: o The clinicians are instructed not to leave the patient unattended during IABP therapy pursuant to Warnings listed in the Operating Manual. o For Blood Detection Alarm - Until the service is performed, clinicians are instructed to follow the Blood Detection Alarm Help Screen found in the operating instruction to validate or clear the alarms. Maquet/Getinge recommends that users review the water condensation procedure (CS100/CS100i and CS300 IABP Operating Instructions section 3.4.1) to reduce the potential for condensation accumulation. In the event the IABP fails to successfully cycle and clear the alarm, remove the IABP from service and contact your local Maquet/Getinge Sales & Service Office. o For Fluid Ingression - Until the service is performed, Maquet/Getinge recommends customers review of the CS100/CS100i and CS300 IABP Operating instructions regarding cautions on placement of fluids and hanging of bags of fluid over the IABP. All facilities will be contacted by a representative of the Maquet/Getinge Service Team to schedule on-site service of your CS100/CS100i or CS300 IABP. Customers are advised to complete and return the Medical Device Field Correction Response Form. Please fax the completed form to 1-973-629-1690 or send via email to [email protected]. If you a distributor has shipped any affected products to customers, please forward a copy of the docu
Quantity in commerce
14,547 units (5,049 domestically & 9,498 units internationally)
Distribution
Worldwide Distribution - US Nationwide International: AFGHANISTAN, ALGERIA, ARGENTINA, AUSTRALIA, AUSTRIA, AZERBAIJAN, BANGLADESH, BELARUS, BELGIUM, BOLIVIA, BOSNIA-HERZEGOVINA, BRAZIL, BRUNEI, BULGARIA, CAMBODIA, CANADA, CHILE, CHINA, COLOMBIA, COLOMBIA, COSTA RICA, CROATIA, CYPRUS, CZECH REPUBLIC, DENMARK, DOMINICAN REPUBLIC, ECUADOR, EGYPT, EL SALVADOR, ESTONIA, FINLAND, FRANCE, GEORGIA, GERMANY, GREECE, GUATEMALA, GUYANA, HONDURAS, HONG KONG, HUNGARY, ICELAND, INDIA, INDONESIA, IRAN, IRAQ, IRELAND, ISRAEL, ITALY, JAPAN, JORDAN, KAZAKHSTAN, KENYA, KOREA, KUWAIT, LATVIA, LEBANON, LIBYA, LITHUANIA, LUXEMBOURG, MACEDONIA, MALAYSIA, MALDIVES, MALTA, MAURITIUS, MEXICO, MOROCCO, MYANMAR, NEPAL, NETHERLANDS, NEW ZEALAND, NORTH KOREA, NORWAY, OMAN, PAKISTAN, PALESTINE, PANAMA, PARAGUAY, PERU, PHILIPPINES, POLAND, PORTUGAL, QATAR, ROMANIA, RUSSIA, SAUDI ARABIA, SERBIA, SINGAPORE, SLOVAKIA, SLOVENIA, SOUTH AFRICA, SOUTH KOREA, SPAIN, SRI LANKA, SWEDEN, SWITZERLAND, SYRIA, TAIWAN, TANZANIA, THAILAND, TRINIDAD, TUNISIA, TURKEY, TURKMENISTAN, UGANDA, UKRAINE, UNITED ARAB EMIRATES, UNITED KINGDOM, URUGUAY, UZBEKISTAN, VENEZUELA, VIETNAM & YEMEN.
Product codes and lots
0998-UC-0446HXX; 0998-UC-0479HXX

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-3085-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-3085-2017Class IOngoingVoluntary: Firm initiated
Z-3086-2017Class IOngoingVoluntary: Firm initiated
Z-3087-2017Class IOngoingVoluntary: Firm initiated